Keyphrases
Adverse Outcomes
14%
Cancer Grade
14%
Cancer Systems
14%
Clinical Follow-up
57%
Degree of Differentiation
14%
Follow-up Interval
14%
Grading Scheme
14%
Grading System
14%
Leiomyosarcoma
100%
Mitotic Rate
28%
Moderately Differentiated
14%
National Cancer Institute
85%
Necrosis
28%
Neoplasms
14%
Poor Differentiation
14%
Prognostic Power
14%
Soft Tissue Sarcoma
14%
Tumor
71%
Urinary Bladder
100%
Well-differentiated
14%
Widespread Adoption
14%
Medicine and Dentistry
Adverse Outcome
8%
Bladder
100%
Cancer Grading
8%
Leiomyosarcoma
100%
Malignant Neoplasm
100%
Mitosis Rate
16%
Necrosis
16%
Neoplasm
50%
Soft Tissue Sarcoma
8%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Outcome
8%
Cancer Grading
8%
Leiomyosarcoma
100%
Malignant Neoplasm
100%
Necrosis
16%
Neoplasm
50%
Soft Tissue Sarcoma
8%
Veterinary Science and Veterinary Medicine
Cancer
100%
Leiomyosarcoma
100%
Mitosis Rate
15%
Neoplasm
46%
Soft-Tissue Sarcoma
7%